Product Information
OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0805 per EA under NDC 68462043730. Its NADAC has been published 485 times since Jun 21, 2017.
FDA first approved this application on May 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462043730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA203281FDA Approved
5/25/2017
TE Code
AB
On Market Since
5/25/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 485 times since Jun 21, 2017, and over the history we have for it it has declined 97.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0805 per EA |
|---|---|
| All-time high | $2.9817 (Jul 12, 2017) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0813 |
| 52-week low | $0.0732 |
| Median price | $0.1070 |
| Average price | $0.1301 |
| Largest weekly change | -94.5% (Jul 19, 2017) |
| Weeks tracked | 485 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olmesartan Medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0805 per EA (NDC 68462043730), effective Sep 30, 2026.
How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 97.3%. It has been tracked across 485 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?
Since Jun 21, 2017, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $2.9817 (Jul 12, 2017), with a median of $0.1070 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 20 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?
OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 68462043730) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.